发明授权
- 专利标题： Method of inhibiting osteoclast activity
- 专利标题（中）： 抑制破骨细胞活性的方法
-
申请号： US12850368申请日： 2010-08-04
-
公开(公告)号： US08333963B2公开(公告)日： 2012-12-18
- 发明人: Dirk M Anderson , Laurent J Galibert
- 申请人： Dirk M Anderson , Laurent J Galibert
- 申请人地址： US CA Thousand Oaks
- 专利权人： Immunex Corporation
- 当前专利权人： Immunex Corporation
- 当前专利权人地址： US CA Thousand Oaks
- 代理商 Scott L. Ausenhus
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/28 ; C07K16/22
摘要：
Methods for inhibiting osteoclastogenesis by administering a soluble RANK polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer.
公开/授权文献
- US20110086033A1 METHOD OF INHIBITING OSTEOCLAST ACTIVITY 公开/授权日：2011-04-14
信息查询
